Abdel-Rahman Omar
Clinical Oncology department, faculty of medicine, Ain Shams University, Cairo, Egypt.
Clin Respir J. 2018 Mar;12(3):1093-1099. doi: 10.1111/crj.12632. Epub 2017 Apr 12.
Small cell lung cancer (SCLC) is a distinct clinical and pathological entity within the spectrum of lung cancer. It was observed that the relative age distribution of the disease changed over years.
Surveillance, epidemiology, and end results (SEER) database (1973-2013) was utilized to determine the incidence, presentation and treatment outcomes of elderly patients (>70 years) with SCLC. Join point regression analysis was then conducted to analyze age-adjusted trends in incidence for the elderly as well as the whole SCLC population. Survival analysis was conducted through Kaplan-Meier analysis. Clinicopathological characteristics and survival outcomes were compared between patients diagnosed at 70-79 years old and those older than 80 years old (octogenarian group).
The proportion of elderly patients among all cases of SCLC increased from 23% in 1975 to 44% in 2010. Moreover, the proportion of elderly female patients among all cases of elderly SCLC increased from 25% in 1975 to 49% in 2010. When categorizing patients into four subgroups "70-74," "75-79," "80-84," and "85+", there was a trend toward a lower cancer-specific survival with increasing age (P < .0001). A limited improvement in 5 year survival was observed during the study period and it is less apparent as the age increases.
The proportion of elderly patients among all cases of SCLC has increased over the past 40 years. Further studies are needed to better select appropriate treatments for this subset of patients.
小细胞肺癌(SCLC)是肺癌谱系中一种独特的临床和病理实体。据观察,该疾病的相对年龄分布多年来有所变化。
利用监测、流行病学和最终结果(SEER)数据库(1973 - 2013年)来确定老年(>70岁)小细胞肺癌患者的发病率、临床表现和治疗结果。然后进行连接点回归分析,以分析老年患者以及整个小细胞肺癌人群发病率的年龄调整趋势。通过Kaplan - Meier分析进行生存分析。比较70 - 79岁诊断的患者与80岁以上(八十岁以上组)患者的临床病理特征和生存结果。
在所有小细胞肺癌病例中,老年患者的比例从1975年的23%增加到2010年的44%。此外,在所有老年小细胞肺癌病例中,老年女性患者的比例从1975年的25%增加到2010年的49%。将患者分为“70 - 74”、“75 - 79”、“80 - 84”和“85岁以上”四个亚组时,癌症特异性生存率有随年龄增加而降低的趋势(P <.0001)。在研究期间观察到5年生存率有有限的改善,且随着年龄增加不太明显。
在过去40年中,所有小细胞肺癌病例中老年患者的比例有所增加。需要进一步研究以更好地为这部分患者选择合适的治疗方法。